Get started
Author

Thomas Schmelter

Observed names: Schmelter, T., Schmelter, Thomas, T Schmelter, T. Schmelter, THOMAS SCHMELTER
Institution: Bayer (Germany)
ORCID: 0000-0003-1358-3172
Observed ORCID: 0000-0003-1358-3172
OpenAlex ID: A5086955368
Intravitreal Aflibercept for Diabetic Macular Edema
2014 · Jean-François Korobelnik, Diana V. Do, et al. · Ophthalmology · 833
PDF
Intravitreal Aflibercept for Diabetic Macular Edema
2015 · David M. Brown, Ursula Schmidt-Erfurth, et al. · Ophthalmology · 629
Intravitreal Aflibercept for Diabetic Macular Edema
2016 · Jeffrey S. Heier, Jean-François Korobelnik, et al. · Ophthalmology · 436
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
2012 · Diana V. Do, Quan Dong Nguyen, et al. · Ophthalmology · 389
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
2024 · Paolo Lanzetta, Jean-François Korobelnik, et al. · The Lancet · 295
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity
2022 · Andreas Stahl, Emine A. Sukgen, et al. · JAMA · 158
Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems
2013 · Anita Nelson, Dan Apter, et al. · Obstetrics and Gynecology · 154
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024 · David M Brown, David S Boyer, et al. · The Lancet · 153
PDF
Monotherapy Administration of Sorafenib in Patients With Non–Small Cell Lung Cancer (MISSION) Trial
2015 · Luis Paz-Ares, Vera Hirsh, et al. · Journal of Thoracic Oncology · 126
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration
2023 · Charles C. Wykoff, David M. Brown, et al. · JAMA Ophthalmology · 121
PDF
Efficacy and Safety of Intravitreal Aflibercept Using a Treat-and-extend Regimen for Neovascular Age-related Macular Degeneration
2021 · Paul Mitchell, Frank G. Holz, et al. · Retina · 105
Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use
2016 · Kristina Gemzell-Danielsson, Dan Apter, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 70
The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial
2018 · Antonia M. Joussen, Sebastian Wolf, et al. · British Journal of Clinical Pharmacology · 65
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial
2015 · Kristina Gemzell-Danielsson, Dan Apter, et al. · PLoS ONE · 61
PDF
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration
2025 · Jean-François Korobelnik, Paolo Lanzetta, et al. · Ophthalmology · 48
Determining the non‐inferiority margin for patient reported outcomes
2011 · Christoph Gerlinger, Thomas Schmelter · Pharmaceutical Statistics · 42
The Optimality of Single-group Designs for Certain Mixed Models
2006 · Thomas Schmelter · Metrika · 41
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study
2021 · Jean-François Korobelnik, Michael Larsen, et al. · American Journal of Ophthalmology · 38
PDF
Intravitreal Nesvacumab (antiangiopoietin 2) Plus Aflibercept in Diabetic Macular Edema
2022 · David M. Brown, David S. Boyer, et al. · Retina · 35
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept
2019 · Justus G. Garweg, Jana Stefanickova, et al. · Ophthalmology Retina · 35
PDF
Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study
2014 · O. Heikinheimo, P. Inki, et al. · Human Reproduction · 34
PDF
Management of Initial Bleeding or Spotting After Levonorgestrel-Releasing Intrauterine System Placement
2013 · Terje Sørdal, Pirjo Inki, et al. · Obstetrics and Gynecology · 34
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity
2024 · Andreas Stahl, Hidehiko Nakanishi, et al. · JAMA Network Open · 33
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women
2013 · David F. Archer, Thomas Schmelter, et al. · Menopause The Journal of The North American Menopause Society · 31
Considerations on group-wise identical designs for linear mixed models
2007 · Thomas Schmelter · Journal of Statistical Planning and Inference · 28
Works count: 78
Citation count: 4,352
H-index: 26
I10-index: 41
Year
Topic
Type